1-3 of 3
Pere Gascon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer

Free
Mercedes Marín-Aguilera, Jordi Codony-Servat, Òscar Reig, Juan José Lozano, Pedro Luis Fernández, María Verónica Pereira, Natalia Jiménez, Michael Donovan, Pere Puig, Lourdes Mengual, Raquel Bermudo, Albert Font, Enrique Gallardo, María José Ribal, Antonio Alcaraz, Pere Gascón, Begoña Mellado
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (5): 1270–1284.
https://doi.org/10.1158/1535-7163.MCT-13-0775
Published: 05 May 2014
View articletitled, Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Open the PDF for Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract C47: Inference of tumor evolution during chemotherapy by computational modeling and single cell analysis of diversity.

Free
Vanessa Almendro, Yu-Kang Cheng, Mithat Gönen, Shalev Itzkovitz, Andriy Marusyk, Elisabet Ametller, Xavier Gonzalez-Farre, Montse Muñoz, Hege Russnes, Åslaug Helland, Inga Rye, Anne Lise Borresen-Dale, Reo Maruyama, Alexander van Oudenaarden, Mitchell Dowsett, Robin L. Jones, Jorge Reis-Filho, Pere Gascon, Franziska Michor, Kornelia Polyak
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C47.
https://doi.org/10.1158/1535-7163.TARG-13-C47
Published: 01 November 2013
View articletitled, Abstract C47: Inference of tumor evolution during chemotherapy by computational modeling and single cell analysis of diversity.
Journal Articles

Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells

Free
Jordi Codony-Servat, Maria A. Tapia, Marta Bosch, Cristina Oliva, Josep Domingo-Domenech, Begoña Mellado, Mark Rolfe, Jeffrey S. Ross, Pere Gascon, Ana Rovira, Joan Albanell
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 665–675.
https://doi.org/10.1158/1535-7163.MCT-05-0147
Published: 16 March 2006
View articletitled, Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
Open the PDF for Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells in another window